Bayesian analysis of signals

Extracting information from signals can be posed as an inverse problem. Since inverse problems are generally ill-posed, the problem is cast in a Bayesian setting. The objective is three-fold: First, estimation of the posterior distribution of model parameters from a given signal. Second, estimation of the posterior of the time shift between two signals. Third, estimation of the joint posterior distribution of a time shift and a model change given two different signals. The MAP solution can be obtained with approximate covariance around the MAP point by iterative search algorithms such as Gauss Newton (GN), and the full posterior solution can be obtained by stochastic processes such as Monte Carlo Markov Chain (MCMC) simulation. For small time- shifts, GN and MCMC yields similar results, making GN a favourable option in these cases as it is computationally much cheaper. Applying these methods to synthetic data using the convolutional model shows good correspondence between the inverted and true parameters for low to medium noise levels

On finite-difference approximations for normalized Bellman equations

A class of stochastic optimal control problems involving optimal stopping is considered. Methods of Krylov are adapted to investigate the numerical solutions of the corresponding normalized Bellman equations and to estimate the rate of convergence of finite difference approximations for the optimal reward functions.Comment: 36 pages, ArXiv version updated to the version accepted in Appl. Math. Opti

Protocol: using virus-induced gene silencing to study the arbuscular mycorrhizal symbiosis in Pisum sativum

Virus-induced gene silencing (VIGS) is an alternative reverse genetics tool for silencing of genes in some plants, which are difficult to transform. The pea early-browning virus (PEBV) has been developed as a VIGS vector and used in pea for functional analysis of several genes. However, the available PEBV-VIGS protocols are inadequate for studying genes involved in the symbiosis with arbuscular mycorrhizal fungi (AMF)

Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections.

To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldHost defenses against Streptococcus pneumoniae depend largely on opsonophagocytosis mediated by antibodies and complement. Since pneumococcus is a respiratory pathogen, mucosal immune responses may play a significant role in the defense against pneumococcal infections. Thus, mucosal vaccination may be an alternative approach to current immunization strategies, but effective adjuvants are required. Protein antigens induce significant mucosal immunoglobulin A (IgA) and systemic IgG responses when administered intranasally (i. n.) with the glyceride-polysorbate based adjuvant RhinoVax (RV) both in experimental animals and humans. The immunogenicity and efficacy of pneumococcal polysaccharide conjugate vaccines (PNC) of serotypes 1 and 3 was studied in mice after i.n. immunization with RV. Antibodies were measured in serum (IgM, IgG, and IgA) and saliva (IgA) and compared to antibody titers induced by parenteral immunization. The PNCs induced significant systemic IgG and IgA antibodies after i.n. immunization only when given with RV and, for serotype 1, serum IgG titers were comparable to titers induced by subcutaneous immunization. In addition, i.n. immunization with PNC-1 in RV elicited detectable mucosal IgA. These results demonstrate that RV is a potent mucosal adjuvant for polysaccharides conjugated to proteins. A majority of the PNC-1-immunized mice were protected against both bacteremia and pneumonia after i.n. challenge with a lethal dose of serotype 1 pneumococci, and protection correlated significantly with the serum IgG titers. Similarly, the survival of mice immunized i.n. with PNC-3 in RV was significantly prolonged. These results indicate that mucosal vaccination with PNC and adjuvants may be an alternative strategy for prevention against pneumococcal infections

Mechanism of salinity change and hydrogeochemical evolution of groundwater in the Machile-Zambezi Basin, South-western Zambia

Machile-Zambezi Basin, South-Western Zambia hosts high salinity groundwater which threatens water security for rural inhabitants. This study investigates the hydrological mechanism that led to high salinity and the geochemical evolution of the groundwater system. The Machile-Zambezi Basin is part of the wider Kalahari Basin which underwent major palaeo-environmental climatic, tectonic and sedimentology dynamics which must have impacted the groundwater salinity. The study examines the groundwater level, hydrochemistry, environmental isotopes (18O/16O, 2H/1H, 3H/3He, 14C/13C). In addition, the sediment cation exchange capacity (CEC) and pore-water chemistry on intact core material were measured. The groundwater chemistry evolved from fresh Ca(Na)HCO3 to saline Na(Ca, Mg)SO4 due to dissolution of salts and not evaporation as indicated by stable isotopes. The saline groundwater is old with 14C ages estimates of more than 1000 years old and stagnant. Geochemical modelling using PHREEQC suggests that ionic exchange due to release of cations from dissolving salts and sulphate reduction were also important processes in this system. High groundwater salinity is therefore associated with Pre-Holocene environmental changes and is restricted to a stagnant saline zone. It will therefore remain unflushed as long as current climatic conditions remain

Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections

To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldHost defenses against Streptococcus pneumoniae depend largely on phagocytosis following opsonization by polysaccharide-specific immunoglobulin G (IgG) antibodies and complement. Since colonization of the respiratory mucosa is the first step in pneumococcal pathogenesis, mucosal immune responses may play a significant role. In addition to inducing systemic immune responses, mucosal vaccination with an effective adjuvant has the advantage of inducing mucosal IgA antibodies. The heat-labile enterotoxin (LT) of Escherichia coli is a well-studied mucosal adjuvant, and adjuvant activity of nontoxic LT mutants has been demonstrated for several protein antigens. We investigated the immunogenicity of pneumococcal polysaccharide conjugate vaccines (PNC) of serotypes 1 and 3 in mice after intranasal (i.n.) immunization by using as an adjuvant the nontoxic LT mutant LT-K63 or LT-R72, which has minimal residual toxicity. Pneumococcal serotype-specific antibodies were measured in serum (IgM, IgG, and IgA) and saliva (IgA), and vaccine-induced protection was evaluated by i.n. challenge with virulent pneumococci of the homologous serotype. When administered with LT mutants, i.n. immunization with both conjugates induced systemic and mucosal immune responses, and serum IgG antibody levels were significantly higher than after subcutaneous immunization. All mice immunized i.n. with PNC-1 and LT mutants were protected against bacteremia and cleared the pneumococci from the lung 24 h after i.n. challenge; pneumococcal density correlated significantly with serum IgG antibody levels. Similarly, the survival of mice immunized i.n. with PNC-3 and LT mutants was significantly prolonged. These results demonstrate that i.n. vaccination with PNC and potent adjuvants can protect mice against invasive and lethal pneumococcal infections, indicating that mucosal vaccination with PNC may be an alternative vaccination strategy for humans